Industry News
Sequencing the yam genome to improve food security
An international research collaboration has provided a genome sequence for the white Guinea yam — a staple crop with huge economic and cultural significance on the African continent. [ + ]
Antibiotic resistance is endemic, not an epidemic — UNSW study
According to a new study from UNSW, antimicrobial resistance (AMR) is not itself an epidemic. Rather, it has the potential to worsen pandemics or seasonal influenza epidemics, and should be kept in perspective. [ + ]
Synthetic molecule directs stem cells to turn into heart muscle cells
Stem cells can now be triggered to change into heart muscle cells thanks to a new method involving synthetic molecules, developed by researchers at Kyoto University. [ + ]
Sirtex penalised for alleged continuous disclosure breach
Sirtex Medical has paid a penalty of $100,000 after the Australian Securities and Investments Commission issued an infringement notice for an alleged failure by the company to comply with its continuous disclosure obligations. [ + ]
Single-cell sequencing system tackles kidney research
Monash University scientists have adopted a Single Cell RNA-Seq System, from Dolomite Bio, to further their research into animal models of diabetic nephropathy. [ + ]
Avita Medical and BARDA execute a US$24.3m contract option
Regenerative medicine company Avita Medical has announced the execution of an expanded contract option valued at approximately US$24.3 million. [ + ]
Deakin University and Chinese biotech company set up lab to develop cancer-detecting blood test
Deakin University and Chinese biotech company Suzhou GenePharma have partnered to develop a blood test that can detect fatal diseases like pancreatic or lung cancer. [ + ]
ComBio2017 to be held in Adelaide next month
ComBio2017 — the combined meeting of the Australian Society for Biochemistry and Molecular Biology, Australian Society of Plant Scientists and Australia and New Zealand Society for Cell and Developmental Biology — will be held at the Adelaide Convention Centre from 2–5 October 2017. [ + ]
Paradigm receives ethics approval for osteoarthritis trial
Paradigm Biopharmaceuticals has received ethics approval for its Phase 2b clinical trial to investigate pentosan polysulfate sodium (PPS) in subjects with knee osteoarthritis (OA) and bone marrow edema lesions (BMELs). [ + ]
WA neurologist appointed president of the World Federation of Neurology
Professor William Carroll, a multiple sclerosis clinician and researcher at Western Australia's Perron Institute for Neurological and Translational Science, has been elected president of the World Federation of Neurology (WFN). [ + ]
Genome editing, OCT4 and human embryo development
UK scientists have used CRISPR-CAS9 to study the role of the OCT4 protein in early human embryo development. [ + ]
MTPConnect and LSQ partner to boost life sciences industry
MTPConnect and LSQ (Life Sciences Queensland Limited) have signed a memorandum of understanding (MoU) to boost the Australian life sciences sector. [ + ]
Personalised medicine trial for childhood cancers
Personalised medicine for childhood cancers in Australia is now one step closer, following the launch of the Zero Childhood Cancer program's national clinical trial. [ + ]
Diabetes drug found to have anti-ageing properties
Australian researchers have discovered that metformin, a common anti-diabetic drug, could have anti-ageing properties which could lead to longer, healthier lifespans. [ + ]
3D bone tissue developed
Researchers have grown three-dimensional samples of mineralised bone from human mesenchymal stem cells without typical osteoinductive media. [ + ]
